Bruce Greenberg | Interim Chief Financial Officer |
Todd Brady | President and Chief Executive Officer |
Marc Goodman | SVB Securities |
Yigal Nochomovitz | Citigroup |
Justin Kim | Oppenheimer & Co. |
Catherine Novack | Jones Research |
Yale Jen | Laidlaw & Company |
Ladies and gentlemen, thank you for standing by, and welcome to the Aldeyra Therapeutics Full Year 2022 Financial Results Conference Call. At this time, all participants are in a listen-only mode. After speakers' presentations, there will be a question-and-answer session.
I would now like to hand the call over to -- the conference call over to Mr. Bruce Greenberg, the company's Interim Chief Financial Officer.